Sai Parenteral's Limited IPO – GMP, Review, Share Price, Subscription, and Details

1.Sai Parenteral's Limited IPO Overview

The initial public offering (IPO) of Sai Parenteral's Limited is a public issue under the Mainboard board. The subscription window is scheduled to open on Mar 24, 2026 and close on Mar 27, 2026, with the price band fixed at ₹372–392 per equity share.

2.Issue Details at a Glance

3.Bidding, Allotment & Listing Timeline

• Bidding opens: Mar 24, 2026
• Bidding closes: Mar 27, 2026
• Allotment date: TBA
• Listing date: 2026-04-02
• Minimum investment: TBA

4.Sai Parenteral's Limited IPO GMP Today

No grey market premium has been recorded for Sai Parenteral's Limited yet. GMP is an informal, unregulated indicator of listing-day sentiment and is not published by any exchange.

5.How to Apply for Sai Parenteral's Limited IPO

1. 1Open IPOGMPTracker or use your broker's app or net banking ASBA facility.
2. 2Search for "Sai Parenteral's Limited IPO" and select it from the list of current issues.
3. 3Choose your demat account and enter your bid quantity in multiples of the —-share lot, at a price within the ₹372–392 band (or bid at cut-off, if eligible).
4. 4Submit the application and approve the UPI mandate request when it arrives — funds stay blocked in your account and are debited only on allotment.

Allotment is expected to be finalised around TBA, with listing tentatively scheduled for 2026-04-02 on BSE and NSE. Once finalised, check your status on the Sai Parenteral's Limited IPO allotment status page.

6.How to Track Subscription & Allotment

• Live subscription: Track QIB, NII and retail bidding on the IPO subscription status page
• Allotment status: Check your application on the IPO allotment status page
• Full IPO details: See dates, lot size, reservation and financials on the Sai Parenteral's Limited IPO page
• More issues: Browse current IPOs, upcoming IPOs and the IPO event calendar

7.Conclusion

Sai Parenteral's Limited opens on Mar 24, 2026 and closes on Mar 27, 2026 at ₹372–392 per share. Read the offer documents in full and consult a qualified adviser before applying — nothing on this page is investment advice.